Mercado de infertilidad masculina: mapeo competitivo y perspectivas estratégicas para 2031

  • Report Code : TIPRE00007061
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 280
Buy Now

[Informe de investigación] Se espera que el mercado de la infertilidad masculina alcance los 6.213,96 millones de dólares en 2027, frente a los 3.883,82 millones de dólares de 2019; se estima que crecerá a una tasa compuesta anual del 6,2 % entre 2020 y 2027.

Factores como el aumento de la infertilidad masculina en todo el mundo y los avances tecnológicos impulsan el crecimiento del mercado. Sin embargo, el alto costo de los procedimientos obstaculiza el crecimiento del mercado de la infertilidad masculina.

Mercados regionales lucrativos para la infertilidad masculina


< p> 

Perspectivas del mercado

Aumento de la fertilidad masculina en todo el mundo

La infertilidad masculina es un problema global con porcentajes de prevalencia que varían de una región a otra. Las deficiencias en el semen y la mala calidad del semen son las principales causas de infertilidad en los hombres. Según los Institutos Nacionales de Salud (NIH), la infertilidad afectó a ~15% de las parejas, es decir, ~48,5 millones de parejas, en todo el mundo en 2016. Además, según una encuesta de investigación publicada en el Journal of Reproductive Biology and Endocrinology, en 2016, la infertilidad Se encontró que la tasa entre los hombres era más alta en África y Europa central y oriental. Según la Organización Mundial de la Salud (OMS), entre ~20% de las parejas infértiles, el problema está en la pareja masculina, mientras que en el 30% de las parejas, el problema existe en ambos miembros de la pareja. Por tanto, los hombres contribuyen a aproximadamente el 50% de los casos de infertilidad a nivel mundial. Además, según Healthy Male Andrology Australia, una división financiada por el Departamento de Salud del Gobierno de Australia, aproximadamente 1 de cada 20 hombres produce una cantidad baja de espermatozoides, lo que provoca infertilidad, y 1 de cada 100 hombres no tiene ningún esperma.

Algunos de los factores comunes responsables de causar infertilidad en los hombres incluyen niveles bajos de producción de hormonas en la glándula pituitaria, problemas sexuales que afectan la entrada del semen en el tracto vaginal y presencia de anticuerpos espermáticos. El varicocele, es decir, la presencia de venas agrandadas en los testículos, es la causa más común de bajo recuento de espermatozoides en los hombres. Según el Departamento de Salud y Servicios Humanos de EE. UU., el varicocele está presente en aproximadamente el 40 % de los hombres que sufren problemas de infertilidad.

Por lo tanto, la asombrosa prevalencia de la infertilidad masculina es generando mayores demandas de tratamientos y servicios de infertilidad masculina.

Información basada en pruebas

El mercado global de infertilidad masculina, basado en pruebas, está segmentado en ADN técnica de fragmentación, análisis de estrés oxidativo, análisis de semen asistido por computadora, examen microscópico, aglutinación de espermatozoides, ensayo de penetración de espermatozoides y otros. El segmento de técnicas de fragmentación de ADN tuvo la mayor participación de mercado en 2019; mientras que se prevé que el segmento de análisis de semen asistido por computadora registre la CAGR más alta del mercado durante el período de pronóstico.

Mercado global de infertilidad masculina, por prueba: 2019 y 2027


Perspectivas basadas en el tipo de tratamiento

El mercado de la infertilidad masculina, según el tipo de tratamiento, se segmenta en tecnología de reproducción asistida y cirugía de varicocele, y medicación. El segmento de tecnología de reproducción asistida y cirugía de varicocele tuvo una mayor participación de mercado en 2019 y se prevé que registre una CAGR más alta en el mercado durante el período de pronóstico.

Distribución Información basada en canales

El mercado de la infertilidad masculina, según el canal de distribución, está segmentado en farmacias de hospitales, farmacias y droguerías, y farmacias en línea. En 2019, el segmento de farmacias hospitalarias tuvo la mayor participación del mercado. Además, se estima que el mercado para el mismo segmento crecerá a la CAGR más alta durante 2020-2027.

Información basada en el usuario final

El El mercado de infertilidad masculina, según el usuario final, se segmenta en centros de fertilidad, hospitales y clínicas, institutos de investigación y otros usuarios finales. En 2019, el segmento de centros de fertilidad tuvo la mayor participación del mercado. Además, se prevé que el mismo segmento registre la CAGR más alta del 6,8 % en el mercado entre 2020 y 2027.

Información estratégica

Empresas como como Vitrolife y Halotech DNA han adoptado varias estrategias orgánicas e inorgánicas para mejorar sus ingresos y su posición en el mercado de la infertilidad masculina. Las actuaciones involucradas de los principales actores han dado como resultado la disponibilidad de mejores servicios y productos en el mercado.

Mercado de infertilidad masculina: por prueba

  • Técnica de fragmentación de ADN
  • Análisis de estrés oxidativo
  • Examen microscópico
  • Aglutinación de esperma
  • Análisis de semen asistido por computadora
  • Ensayo de penetración de espermatozoides
  • Otros


Mercado de infertilidad masculina - ndash; por tipo de tratamiento

  • Tecnología de reproducción asistida
    • Fertilización in vitro (FIV)
    • Inyección intracitoplasmática de espermatozoides (ICSI)
  • Cirugía de varicocele
  • Medicamentos


Mercado de la infertilidad masculina – ndash; por Canal de Distribución

  • Hospitales Farmacias
  • Farmacias y Droguerías
  • Farmacias Online


Hombre Mercado de infertilidad: por usuario final

  • Hospitales y clínicas
  • Centros de fertilidad
  • Institutos de investigación
  • Otros usuarios finales

  • Mercado de infertilidad masculina - ndash; por Geografía

    • América del Norte
      • Estados Unidos
      • Canadá
      • México
    • < li>Europa
      • Alemania
      • Reino Unido
      • Francia
      • Italia
      • España
      • Suecia
      • Dinamarca
      • Polonia
      • Turquía
      • Países Bajos
      • Bélgica
      • Finlandia< /li>
      • Suiza
      • Irlanda
      • Noruega
      • Resto de Europa
    • Asia Pacífico (APAC)
      • Japón
      • China
      • India
      • Corea del Sur
      • Australia
      • Tailandia
      • Singapur
      • Nueva Zelanda
      • Vietnam
      • Resto de Asia Pacífico
    • < li>Oriente Medio y África (MEA)
      • EAU
      • Arabia Saudita
      • Sudáfrica
      • Egipto
      • Israel
      • Resto de Medio Oriente y África
    • América del Sur y Central (SCAM)
      • Brasil
      • Argentina
      • Resto de América del Sur y Central

    Perfiles de empresas

    • MERCK KGaA
    • Sanofi
    • Bayer AG
    • Endo Pharmaceuticals Inc.
    • SCSA Diagnostics, Inc.
    • < li>Soluciones de andrología
    • ADN Halotech
    • INTAS PHARMACEUTICALS LTD.
    • Cadila Pharmaceuticals Ltd.
    • Vitrolife
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is male infertility?

Male infertility is due to low sperm production, abnormal sperm function or blockages that prevent the delivery of sperm. Illnesses, injuries, chronic health problems, lifestyle choices such as Smoking, drinking alcohol, and taking certain medications can lower sperm numbers. Other causes of low sperm numbers include long-term sickness (such as kidney failure), childhood infections (such as mumps), and chromosome or hormone problems (such as low testosterone). In over a third of infertility cases, the problem is with the man. This is most often due to problems with the sperm production or with sperm delivery.

What are the driving factors for the male infertility market across the globe?

The male infertility market is estimated to grow owing to key driving factors such as increasing infertility rate, rising adoption of assisted reproductive technologies (ART), and a shift towards sedentary lifestyle across the globe. However, high cost of the procedures is likely to hamper the growth of the market during the forecast period.

What is the regional market scenario of male infertility?

Global male infertility market is segmented by region into North America, Europe, Asia-Pacific, Middle East & Africa and South & Central America. In North America, the U.S. holds a significant share of the male infertility market. Innovations in the product line primarily drive the growth of the market in the country. The country focuses on changing the overall landscape and the best in the class healthcare infrastructure, advanced facilities, and awareness and openness amongst citizens towards the disease.The increasing infertility rate in the country is the primary factor driving growth during the study period. For instance, Infertility is a common problem, with more than 5 million couples in the United States dealing with these problems. It affects one in every six couples who are trying to conceive. In at least half of all cases of Infertility, a malefactor is a primary or contributing cause. This means that about 10% of all men in the United States attempting to conceive suffer from Infertility.

The List of Companies - Male Infertility Market

  1. MERCK KGaA
  2. Sanofi
  3. Bayer AG
  4. Endo Pharmaceuticals Inc.
  5. SCSA Diagnostics, Inc.
  6. Andrology Solutions
  7. Halotech DNA
  8. INTAS PHARMACEUTICALS LTD.
  9. Cadila Pharmaceuticals Ltd.
  10. Vitrolife.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports